Singapore, April 13 -- Australia-based Telix Pharmaceuticals and US-based Regeneron Pharmaceuticals, Inc. have announced a collaboration to jointly develop and commercialise next generation radiopharmaceutical therapies.
Published by HT Digital Content Services with permission from BioSpectrum Asia....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.
